Last reviewed · How we verify
NCT07373977
Comparison of Postoperative Pain After Pulpotomy Performed With Versus Without Dental Operating Microscope in Carious Mature Permanent Teeth
EARLY_PHASE1 trial testing Using dental operating microscope in Carious Exposure of Pulp in 82 participants. Not yet recruiting.
28 December 2026
Quick facts
| Lead sponsor | Chulalongkorn University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 82 |
| Start date | 10 February 2026 |
| Primary completion | 28 December 2026 |
| Estimated completion | 31 December 2026 |
Drugs / interventions tested
- Using dental operating microscope
Conditions studied
- Carious Exposure of Pulp — all drugs for Carious Exposure of Pulp →
Sponsor
Chulalongkorn University
Who can join
18 and older, any sex, with Carious Exposure of Pulp. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this \[randomized clinical trials\] is to investigate the effect of using dental operating microscope incorperated in full pulpotomy procedure in mature carious posterior teeth. The main questions it aims to answer are: investigate postoperative pain levels. investigate the quality of life of patient after treatment. If there is a comparison group: Researchers will compare the pulpotomy procedure with and without using dental operating microscope. Participants will will be asked to do * Pain evaluation with numerical rating scale * OHIP 14 survey before and after treatment
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07373977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Carious Exposure of Pulp
Currently open trials in the same condition.
- NCT05937100 — New Vital Pulpotomy Medications in Primary Molars · NA · active not recruiting
Other Chulalongkorn University trials
Trials by the same sponsor.
- NCT07458659 — Clinical Study of BCMA-Targeted CAR T-Cell Injection in the Treatment of Patients With Relapsed/Refractory Multiple Myel · EARLY_PHASE1 · not yet recruiting
- NCT07346118 — Fluid Balance Guided by Modified Venous Excess Ultrasonography Versus Standard Care in Patients With Acute Kidney Injury · NA · not yet recruiting
- NCT07388862 — Comparison of Treatment Outcome of Pulpotomy With Versus Without Dental Operating Microscope in Carious Mature Permanent · EARLY_PHASE1 · not yet recruiting
- NCT07078929 — Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL · Phase 1 · recruiting
- NCT07453134 — Treatment Outcome and Patient-reported Outcomes in Patient Undergoing Non-surgical Root Canal Treatment With Different I · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07373977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chulalongkorn University
- Last refreshed: 30 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07373977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing